UK prospective diabetes study (UKPDS) (original) (raw)
Zimmet P (1982) Type 2 (non-insulin dependent) diabetes: an epidemiological overview. Diabetologia 22: 399–411 ArticlePubMed Google Scholar
Mather HM, Keen H (1985) The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J 291: 1081–1084 Google Scholar
Garcia MJ, McNamara PM, Gordon T, Kannell WB (1974) Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23: 105–111 PubMed Google Scholar
Panzram G (1987) Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 123–131 ArticlePubMed Google Scholar
Panzram G, Zabel-Langhennig R (1981) Prognosis of diabetes mellitus in a geographically defined population. Diabetologia 20: 587–591 ArticlePubMed Google Scholar
Laing W, Williams DRR (1989) Diabetes, a model for health care management. Office of Health Economics, London UK, No 92: 32–49 Google Scholar
University Group Diabetes Program. Knatterud GL, Klimt CR, Levin ME, Jacobson ME, Goldner MG (1978) Effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment. JAMA 240: 37–42 PubMed Google Scholar
Jarrett RJ, Keen H (1976) Hyperglycaemia and diabetes mellitus. Lancet II: 1009–1012 Article Google Scholar
Pettitt DJ, Knowler WC, Lisse JR, Bennett PH (1980) Development of retinopathy and proteinuria in relation to plasma glucose concentration in Pima Indians. Lancet II: 1050–1052 Google Scholar
Dornan TL, Mann JI, Turner RC (1982) Factors protective against retinopathy in insulin-dependent diabetics free of retinopathy for 30 years. Br Med J 285: 1073–1077 Google Scholar
McCance DR, Hadden DR, Atkinson AB, Archer DB, Kennedy L (1989) Long-term glycaemic control and diabetic retinopathy. Lancet II: 824–828 Article Google Scholar
Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T and the Steno Study Group (1985) Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 34 [Suppl 3]: 74–79 Google Scholar
The Kroc Collaborative Study Group (1988) Diabetic retinopathy after two years of intensified insulin treatment. JAMA 260: 37–41 Google Scholar
Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF et al. (1986) Effect of mean normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy; the Oslo Study. Br Med J 293: 1195–1199 Google Scholar
Bilous RW, Mauer SM, Sutherland DE, Najarian JS, Goetz FC, Steffes MW (1989) The effects of pancreas transplantation on the glomerular structure of renal allographs in patients with insulin-dependent diabetes. N Engl J Med 321: 80–85 PubMed Google Scholar
Kennedy WR, Navarro X, Goetz FC, Sutherland DER, Najarian JS (1990) Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 322: 1031–1037 PubMed Google Scholar
Holman RR, Turner RC (1980) The basal plasma glucose: a simple, relevant index of maturity-onset diabetes. Clin Endocrinol 14: 279–286 Google Scholar
Howe-Davies S, Simpson RW, Turner RC (1980) Control of maturity-onset diabetes by monitoring fasting blood glucose and body weight. Diab Care 3: 607–610 Google Scholar
Holman RR, Turner RC (1977) Diabetes: the quest for basal normoglycaemia. Lancet I: 469–474 Article Google Scholar
WHO Study Group (1985) Diabetes mellitus. World Health Organisation Technical Report Series No 727. WHO, Geneva Google Scholar
Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary-heart disease risk and impaired glucose tolerance. The Whitehall study. Lancet I: 1373–1376 Google Scholar
Eschwège E, Richard JL, Thibult N et al. (1985) Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res [Suppl 15]: 41–46
Stamler R, Stamler J (1979) Asymptomatic hyperglycaemia and coronary heart disease. A series of papers by the International Collaborative Group based on studies in fifteen populations. J Chron Dis 32: 683–837 ArticlePubMed Google Scholar
Fontbonne A, Charles MA, Thibult N et al. (1991) Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15 year followup. Diabetologia 34: 356–361 PubMed Google Scholar
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607 CASPubMed Google Scholar
Fontbonne A, Eschwège E, Cambien F et al. (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32: 300–304 ArticlePubMed Google Scholar
University Group Diabetic Program (1970) A study of the effects of hypoglycaemic agents on vascular complications on patients with adult-onset diabetes II. Mortality results. Diabetes 19 [Suppl 2]: 789–830 Google Scholar
Keen H, Jarrett RJ, Fuller J (1973) Tolbutamide and arterial disease in borderline diabetics. Excerpta Medica Int Congress Series 312: 588–602 Google Scholar
Sartor G, Schersten B, Carlstrom S, Melander A, Norden A, Persson G (1980) Ten-year follow-up of subjects with impaired glucose tolerance. Prevention of diabetes by tolbutamide and diet regulation. Diabetes 29: 41–49 PubMed Google Scholar
The DCCT Research Group (1986) The diabetes control and complications trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 35: 530–544 Google Scholar
Hermann LS (1979) Metformin: a review of its pharmacological properties and therapeutic use. Diab Metab Rev 5: 233–245 Google Scholar
Standl E, Stiegler H, Roth R, Schulz K, Lehmacher W (1989) On the impact of hypertension on the prognosis of NIDDM. Results of the Schwabing GP-Program. Diab Metab 15: 352–358 Google Scholar
Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: principal results. Br Med J 291: 97–104 Google Scholar
Australian National Blood Pressure Study Management Committee (1980) The Australian Therapeutic trial in mild hypertension. Lancet I: 1261–1267 Google Scholar
Collins R, Peto R, MacMahon S et al. (1990) Blood pressure, stroke, and coronary heart disease: part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335: 827–838 ArticlePubMed Google Scholar
Chobanian AV (1986) Antihypertensive therapy in evolution. N Engl J Med 314: 1701–1702 PubMed Google Scholar
Christensen CK, Mogensen CE (1987) Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function. J Diab Compl 1: 45–52 Google Scholar
Mogensen CE (1982) Long term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 685–688 Google Scholar
Parving H-H, Anderson AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br J Med 294: 1443–1447 Google Scholar
Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T (1989) Improved survival in patients with diabetic nephropathy. Diabetologia 32: 884–886 ArticlePubMed Google Scholar
Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 27: 335–371 PubMed Google Scholar
Wilkstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G (1988) Primary prevention with metoprolol in patients with hypertension. JAMA 259: 1976–1982 PubMed Google Scholar
Hommel E, Parving HH, Mathiesen E, Edsberg B, Nielsen MD, Giese J (1986) Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 293: 467–470 Google Scholar
Parving HH, Hommel E, Damkjær Nielsen M, Giese J (1989) Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. Br Med J 299: 533–536 Google Scholar
Hostetter TH, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375–378 ArticlePubMed Google Scholar
Zatz R, Rentz Dunn B, Meyer TW, Anderson S, Rennke HG, Brennen BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925–1930 PubMed Google Scholar
Dzau VJ (1988) Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77 [Suppl 1]: 4–13 Google Scholar
Dzau VJ (1986) Significance of the vascular renin-angiotensin pathway. Hypertension 8: 553–559 PubMed Google Scholar
Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM (1991) Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68: 450–456 PubMed Google Scholar
Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Ranagh JH (1991) Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 324: 1098–1104 PubMed Google Scholar
Deau VJ (1991) Renin and myocardial infarction in hypertension. N Engl J Med 324: 1128–1130 PubMed Google Scholar
Abert G, Ferrer P (1990) Effects of captopil on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharm 15: S65-S72 Google Scholar
Powell JS, Clozel JP, Muller RKM et al. (1989) Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186–188 PubMed Google Scholar
Sawicki PT, Mühlhauser I, Baba T, Berger M (1990) Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus? Diabetologia 33: 121–124 PubMed Google Scholar
United Kingdom Prospective Diabetes Study (1985) III. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes. Hypertension 7 [Suppl 2]: 8–13 Google Scholar
United Kingdom Prospective Diabetes Study (1983) I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year. Diabetologia 24: 404–411 Google Scholar
Holman RR, Turner RC (1978) Basal normoglycaemia attained with chlorpropamide in mild diabetes. Metabolism 27: 539–547 ArticlePubMed Google Scholar
Holman RR, Steemson J, Darling P, Reeves WG, Turner RC (1984) Human ultralente insulin. Br Med J 288: 665–668 Google Scholar
Metropolitan Life Insurance Company (1959) New weight standard for men and women. Stat Bull Metropolitan Life 40: 1–4 Google Scholar
Holman RR, Turner RC (1985) A practical guide to basal and prandial insulin therapy. Diab Med 2: 45–53 Google Scholar
Phillips M, Simpson RW, Holman RR, Turner RC (1979) A simple and rational twice daily subcutaneous insulin regime. Distinction between basal and meal insulin requirement. Quart J Med 48: 493–506 PubMed Google Scholar
Turner RC, Holman RR, Matthews DR (1988) Sulphonylurea failure and inadequacy. In: Cameron D, Colagiuri S, Heding L (eds) Excerpta Medica, Amsterdam. Novo Symposium, Hamilton Island, pp 52–56 Google Scholar
United Kingdom Prospective Diabetes Study (1988) IV. Characteristics of newly-presenting type 2 diabetic patients: male preponderance and obesity at different ages. Diab Med 5: 154–159 Google Scholar
United Kingdom Prospective Diabetes Study (1990) VI. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diab Res 13: 1–11 Google Scholar
Wright BM, Dore CF (1970) A random-zero sphygmomanometer. Lancet I: 33–35 Google Scholar
Ferris FL, Kassoff A, Bresnick GH, Bailey I (1982) New visual charts for clinical research. Am J Ophthalmol 94: 91–96 PubMed Google Scholar
Davis MD, Hubbard LD, Tarutmann J (1985) Studies of retinopathy; methodology assessment and classification with fundus photographs. Diabetes 35 [Suppl]: 42–49 Google Scholar
Bloom S, Till S, Sonksen P, Smith S (1984) Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects. Br J Med 288: 1793–1795 Google Scholar
Ewing DJ, Borsey DQ, Bellavere F, Clarke BF (1981) Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia 21: 18–24 PubMed Google Scholar
Ewing DJ, Campbell IW, Murray A, Neilson JMM, Clarke BF (1978) Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. Br Med J 1: 145–147 PubMed Google Scholar
Rose GA, Blackburn H, Gillum RF, Prineas RJ (1982) Cardiovascular survey methods, 2nd edn. World Health Organisation, Geneva Google Scholar
Davis JE, McDonald JM, Jarett L (1978) A high performance liquid chromatography method for haemoglobin Alc. Diabetes 27: 102–107 PubMed Google Scholar
Wahlefeld AW (1974) Triglycerides. Determination after enzymatic hydrolysis. In: Bergmeyer M (ed) Methods of enzymatic analysis, 2nd edn, Vol.4. Verlag Chemie, Weinheim and Academic Press, New York London, pp 1831–1835 Google Scholar
Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW (1981) Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 19: 838–839 Google Scholar
Burstein M, Scholnick HR, Morfin R (1970) Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11: 583–594 PubMed Google Scholar
Moore JC, Morris JE (1982) A simple automated colorimetric method for determination of N-acetyl-B-D-glucosaminidase. Ann Clin Biochem 19: 157–159 PubMed Google Scholar
Albano JM, Ekins RP, Maritz G, Turner RC (1972) A sensitive precise radio-immunoassay of human insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 70: 487–509 PubMed Google Scholar
Kearney EM, Mount JN, Watts GF, Slavin BM, Kind PRN (1987) Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser. J Clin Path 40: 465–468 PubMed Google Scholar
Henry RJ, Cannon DC, Winkelman JW (1974) Clinical chemistry; principles and technics. Harper & Row, Hagerstown, pp 552–553 Google Scholar
Ginsberg JM, Chang BS, Matarese RA, Garella S (1983) Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309: 1543–1546 PubMed Google Scholar
Yuen CT, Kind PRN, Price RG, Praill PFG, Richardson AC (1984) Colorimetric assay for N-acetyl-beta-D-glucosaminidase (NAG) in pathological urine using the omega W-nitrostyryl substrate: the development of a kit and the comparison of manual procedure with the automated fluorimetric method. Ann Clin Biochem 21: 295–300 PubMed Google Scholar
Westgard JO, Barry PL, Hunt MR (1981) A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem 27: 493–501 PubMed Google Scholar
International classification of procedures in medicine (1978) World Health Organisation. Geneva
Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmus U, Murrells TJ (1984) Microalbuminuria predicts mortality in noninsulin-dependent diabetes. Diab Med 1: 17–19 Google Scholar
Mogensen CE (1986) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356–360 Google Scholar
Schmitz A, Vaeth M (1988) Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diab Med 5: 126–134 Google Scholar
Stratton IM, Holman RR, Oakes SM, Turner RC for UK Prospective Diabetes Study Group (1991) Randomised trial of tight blood pressure control with ACE inhibitor or B-blocker compared with less tight control in Type II diabetic patients. Diabetes 40 [Suppl 1]: 369 (Abstract) Google Scholar